| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1968 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 675 | 2022 |
| Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, GT Culbreth, LM Haile, Q Rafferty, J Lo, KG Fukutaki, ... The Lancet Rheumatology 5 (9), e508-e522, 2023 | 563 | 2023 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The Lancet Gastroenterology & Hepatology 7 (7), 627-647, 2022 | 386 | 2022 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 303 | 2023 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 202 | 2022 |
| Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 RJ Black, M Cross, LM Haile, GT Culbreth, JD Steinmetz, H Hagins, ... The Lancet Rheumatology 5 (10), e594-e610, 2023 | 197 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 180 | 2022 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 180 | 2022 |
| Effect of dextrose prolotherapy, platelet rich plasma and autologous conditioned serum on knee osteoarthritis: a randomized clinical trial A Pishgahi, R Abolhasan, SK Shakouri, MS Soltani-Zangbar, S Dareshiri, ... Iranian Journal of Allergy, Asthma and Immunology, 243-252, 2020 | 68 | 2020 |
| Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy R Motavalli, J Etemadi, MS Soltani-Zangbar, MR Ardalan, H Kahroba, ... Cytokine 141, 155452, 2021 | 65 | 2021 |
| Anti-mucin1 aptamer-conjugated chitosan nanoparticles for targeted co-delivery of docetaxel and IGF-1R siRNA to SKBR3 metastatic breast cancer cells R Jafari, NM Zolbanin, J Majidi, F Atyabi, M Yousefi, F Jadidi-Niaragh, ... Iranian Biomedical Journal 23 (1), 21, 2019 | 63 | 2019 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 54 | 2023 |
| Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs C Aslan, S Maralbashi, H Kahroba, M Asadi, MS Soltani-Zangbar, ... Life Sciences 258, 118094, 2020 | 54 | 2020 |
| Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome G Sheikhansari, MS Soltani‐Zangbar, Z Pourmoghadam, A Kamrani, ... American Journal of Reproductive Immunology 82 (4), e13170, 2019 | 54 | 2019 |
| IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss S Danaii, F Ghorbani, M Ahmadi, H Abbaszadeh, L Koushaeian, ... International immunopharmacology 87, 106806, 2020 | 53 | 2020 |
| Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome A Pishgahi, R Abolhasan, S Danaii, B Amanifar, MS Soltani-Zangbar, ... Cytokine 128, 155002, 2020 | 48 | 2020 |
| Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss R Azizi, MS Soltani-Zangbar, Z Pourmoghadam, A Mehdizadeh, ... Journal of reproductive immunology 133, 18-26, 2019 | 47 | 2019 |
| Intrauterine administration of autologous hCG-activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double … Z Pourmoghadam, MS Soltani-Zangbar, G Sheikhansari, R Azizi, ... Journal of Reproductive Immunology 142, 103182, 2020 | 43 | 2020 |
| Exosomes: emerging biomarkers and targets in folliculogenesis and endometriosis N Shomali, M Hemmatzadeh, Y Yousefzadeh, MS Soltani-Zangbar, ... Journal of Reproductive Immunology 142, 103181, 2020 | 41 | 2020 |
Mehdi YousefiTabriz University of Medical SciencesE-mail confirmado em tbzmed.ac.ir